SurvivorNet on MSN7mon
New Hope for Ovarian Cancer: FDA Approves Targeted Drug ELAHERE for Certain Patients With Difficult-to-Manage Disease
To simplify, ELAHERE is for ovarian cancer patients that express a folate-receptor target and still have disease progression ...
Medical News Today28d
Elahere side effects: What you should know
These are just a few of the more common side effects reported by people who took Elahere in clinical trials: Mild side effects can occur with Elahere use. This list doesn’t include all possible ...
Hosted on MSN7mon
Elahere secures full approval from FDA for types of ovarian cancer
AbbVie’s monoclonal antibody Elahere (mirvetuximab soravtansine-gynx) has bagged full approval from the US Food and Drug Administration (FDA) for the treatment of certain types of ovarian cancer.
Medscape7d
Ocular Side Effects Common in Real-World Study of Cancer Tx
CHICAGO — A real-world study of the ocular side effects of the gynecological cancer treatment mirvetuximab (Elahere) has ...